O00267 (SPT5H_HUMAN) Homo sapiens (Human)

Transcription elongation factor SPT5 UniProtKBInterProSTRINGInteractive Modelling

1087 aa; Sequence (Fasta) ; (Isoform 2)

Available Structures

34 Experimental Structures

DescriptionPDB IDOligo-stateRangeSeq id (%)Ligands
Structure of mammalian Pol II-DSIF-SPT6-PAF1-TFIIS-hexasome elongation complex Heteromer
A0A287ADR4; A0A4X1VKG7; A0A4X1VYD0; A0A7M4DUC2; A0A8D0JYF1; A0A8D1KNW4; A0A8J1LZU9; F1RKE4; I3LCB2; I3LCH3; I3LGP4; I3LSI7; P60899; P62799; P84233; Q4R941; Q6AZJ8; Q6P1J9; Q6PD62; Q8N7H5; Q8WVC0; Q92541; Q9GZS3;
176-781
100.0ZN;MG;
Pol II-DSIF-SPT6-PAF1c-TFIIS-nucleosome complex (stalled at +38) Heteromer
A0A481DF93; A0A4X1TRS6; A0A4X1TVZ5; A0A4X1VEK9; A0A4X1VKG7; A0A4X1VTX4; A0A7M4DUC2; A0A8D1GCS3; P02281; P23193; P62799; P63272; P84233; Q6AZJ8; Q6P1J9; Q6PD62; Q7KZ85; Q8N7H5; Q8WVC0; Q92541; Q9GZS3;
176-781
100.0ZN;MG;
Structure of complete, activated transcription complex Pol II-DSIF-PAF-SPT6 uncovers allosteric elo… Heteromer
A0A287ADR4; A0A4X1TRS6; A0A4X1VEK9; A0A4X1VYD0; F1RKE4; I3LCB2; I3LCH3; I3LGP4; I3LSI7; P60899; P63272; Q6P1J9; Q6PD62; Q7KZ85; Q8N7H5; Q8WVC0; Q92541; Q9GZS3;
176-781
100.0ZN;MG;
The structure of INTAC-PEC complex Heteromer
A0A4X1TRS6; A0A4X1VEK9; A0A4X1VKG7; A0A4X1VM56; A0A8W4F9W9; F1RKE4; I3LCB2; I3LCH3; I3LGP4; I3LSI7; P18615; P24928; P30153; P60899; P63272; P67775; Q5TA45; Q6P9B9; Q75QN2; Q8IXH7; Q8N201; Q8WX92; Q96HW7; Q9H0H0; Q9H3P2; Q9NV88; Q9NVH2; Q9UL03;
176-756
100.010×ZN;MN;MG;
Structure of an RNA polymerase II-DSIF transcription elongation complex Heteromer
A5PJW8; F2Z4H3; G3MZY8; P63272; Q1JQ91; Q2T9T3; Q32P73; Q32P78; Q32P79; Q32PE0; Q3T0Q3; Q3ZBC0; Q5E9B8;
176-754
100.0ZN;MG;
Structural insights into human co-transcriptional capping - structure 6 Heteromer
A0A4X1TRS6; A0A4X1VEK9; A0A4X1VKG7; A0A4X1VM56; A0A4X1VYD0; A0A8D1DPV6; F1RKE4; I3LCB2; I3LCH3; I3LGP4; I3LSI7; P60899; P63272; Q8N1G2;
176-754
100.0MGT;ZN;MG;SAM;
Structure of activated transcription complex Pol II-DSIF-PAF-SPT6 Heteromer
A0A287ADR4; A0A4X1TRS6; A0A4X1VEK9; F1RKE4; I3LCB2; I3LCH3; I3LGP4; I3LJR4; I3LSI7; P60899; P63272; Q6PD62; Q7KZ85; Q9GZS3;
176-754
100.0ZN;MG;
Structure of paused transcription complex Pol II-DSIF-NELF - tilted Heteromer
A0A4X1TRS6; A0A4X1VEK9; A0A4X1VKG7; A0A4X1VM56; A0A8D1DPV6; A0A8W4F9W9; F1RKE4; I3LCB2; I3LCH3; I3LGP4; I3LSI7; P18615; P60899; P63272; Q8IXH7; Q8WX92; Q9H3P2;
176-753
100.0ZN;MG;
human co-transcriptional RNA capping enzyme RNGTT Heteromer
A0A4X1TRS6; A0A4X1VEK9; A0A4X1VKG7; A0A4X1VM56; A0A8D1DPV6; A0A8W4F9W9; F1RKE4; I3LCB2; I3LCH3; I3LGP4; I3LSI7; O60942; P18615; P60899; P63272; Q8IXH7; Q8WX92; Q9H3P2;
176-753
100.0MG;ZN;GTP;
human co-transcriptional RNA capping enzyme RNGTT-CMTR1 Heteromer
A0A4X1TRS6; A0A4X1VEK9; A0A4X1VKG7; A0A4X1VM56; A0A8D1DPV6; A0A8W4F9W9; F1RKE4; I3LCB2; I3LCH3; I3LGP4; I3LSI7; O60942; P60899; P63272; Q8N1G2;
176-753
100.0MG;ZN;GTP;
Structural insights into human co-transcriptional capping - structure 3 Heteromer
A0A4X1TRS6; A0A4X1VEK9; A0A4X1VKG7; A0A4X1VM56; A0A8D1DPV6; A0A8W4F9W9; F1RKE4; I3LCB2; I3LCH3; I3LGP4; I3LSI7; O60942; P60899; P63272;
176-753
100.0ZN;MG;
Structural insights into human co-transcriptional capping - structure 4 Heteromer
A0A4X1TRS6; A0A4X1VEK9; A0A4X1VKG7; A0A4X1VM56; A0A8D1DPV6; A0A8W4F9W9; F1RKE4; I3LCB2; I3LCH3; I3LGP4; I3LSI7; O60942; P60899; P63272;
176-753
100.0ZN;
Structure of active transcription elongation complex Pol II-DSIF-ELL2-EAF1(composite structure) Heteromer
A0A287ADR4; A0A4X1TRS6; A0A4X1VEK9; A0A4X1VYD0; A0A7M4DUC2; F1RKE4; I3LCB2; I3LCH3; I3LGP4; I3LSI7; O00472; P60899; P63272; Q96JC9;
176-753
100.0MG;ZN;
Structure of paused transcription complex Pol II-DSIF-NELF Heteromer
A0A287ADR4; A0A4X1TRS6; A0A4X1VEK9; F1RKE4; I3LCB2; I3LCH3; I3LGP4; I3LJR4; I3LSI7; P60899; P63272; Q8IXH7; Q8WX92; Q9H3P2;
176-753
100.0MG;ZN;
Structure of paused transcription complex Pol II-DSIF-NELF - post-translocated Heteromer
A0A4X1TRS6; A0A4X1VEK9; A0A4X1VKG7; A0A8D0KES4; A0A8D0TE17; A0A8D1AQR7; A0A8D1DPV6; A0A8W4F9W9; I3LCH3; I3LGP4; I3LSI7; P18615; P60899; P63272; Q8IXH7; Q8WX92; Q9H3P2;
176-753
100.0ZN;MG;
Pol II-DSIF-SPT6-PAF1c-TFIIS complex with rewrapped nucleosome Heteromer
A0A481DF93; A0A4X1TRS6; A0A4X1TVZ5; A0A4X1VEK9; A0A4X1VKG7; A0A4X1VTX4; A0A7M4DUC2; A0A8D1GCS3; P02281; P23193; P62799; P84233; Q6AZJ8; Q6P1J9; Q6PD62; Q7KZ85; Q8N7H5; Q8WVC0; Q92541; Q9GZS3;
416-781
100.0ZN;MG;
Structure of transcription complex Pol II-DSIF-NELF-TFIIS Heteromer
A0A4X1VEK9; A0A4X1VKG7; A0A4X1VM56; A0A8D0JYF1; A0A8D1DPV6; A0A8W4F9W9; F1RKE4; I3LCB2; I3LCH3; I3LGP4; I3LSI7; P23193; P60899; Q8IXH7; Q9H3P2;
416-753
100.0ZN;MG;
Structure of poised transcription complex Pol II-DSIF-NELF - pre-translocated Heteromer
A0A4X1TRS6; A0A4X1VEK9; A0A4X1VKG7; A0A4X1VM56; A0A8D1DPV6; A0A8W4F9W9; F1RKE4; I3LCB2; I3LCH3; I3LGP4; I3LSI7; P18615; P60899; Q8IXH7; Q8WX92; Q9H3P2;
416-753
100.0ZN;MG;
Structure of paused transcription complex Pol II-DSIF-NELF - poised post-translocated Heteromer
A0A4X1TRS6; A0A4X1VEK9; A0A4X1VKG7; A0A4X1VM56; A0A8D1DPV6; A0A8W4F9W9; F1RKE4; I3LCB2; I3LCH3; I3LGP4; I3LSI7; P18615; P60899; Q8IXH7; Q8WX92; Q9H3P2;
416-753
100.0ZN;MG;
Structural basis of Integrator-mediated transcription regulation Heteromer
A0A0B8RVL1; A0A287ADR4; A0A481DF93; A0A4X1TRS6; A0A4X1VEK9; A0A7K6NXI9; A0A7M4DUC2; F1RKE4; I3LCB2; I3LJR4; I3LSI7; P30153; P60899; P67775; Q5TA45; Q6P9B9; Q75QN2; Q8IXH7; Q8N201; Q8WX92; Q96HW7; Q9H0H0; Q9H3P2; Q9NV88; Q9NVH2; Q9UL03;
416-753
100.0MG; 10×ZN;MN;
Structure of Integrator-PP2A bound to a paused RNA polymerase II-DSIF-NELF-nucleosome complex Heteromer
A0A287ADR4; A0A4X1VEK9; A0A4X1VKG7; A0A4X1VYD0; A0A8D0JYF1; A0A8D1DPV6; F1RKE4; I3LCB2; I3LCH3; I3LGP4; I3LSI7; P06899; P0C0S8; P30153; P60899; P62805; P67775; Q5TA45; Q6NXT2; Q6P9B9; Q75QN2; Q8IXH7; Q8N201; Q8WX92; Q96HW7; Q96N11; Q96SY0; Q9H0H0; Q9H3P2; Q9NV88; Q9NVH2; Q9NVM9; Q9NVR2; Q9UL03;
416-753
100.010×ZN;MG;MN;
Crystal structure of the human transcription elongation factor DSIF, hSpt4/hSpt5 (176-273) Heteromer
P63272;
176-269
100BME;ZN;
Structural insights into human co-transcriptional capping - structure 5 Heteromer
A0A4X1TRS6; A0A4X1VEK9; A0A4X1VKG7; A0A4X1VM56; A0A8W4F9W9; F1RKE4; I3LCB2; I3LCH3; I3LGP4; I3LSI7; O60942; P11414; P60899; Q8N1G2;
703-754
100MG;ZN;
Structure of active transcription elongation complex Pol II-DSIF (SPT5-KOW5) Heteromer
A0A287ADR4; A0A4X1TRS6; A0A4X1VEK9; A0A4X1VYD0; A0A7M4DUC2; F1RKE4; I3LCB2; I3LCH3; I3LGP4; I3LSI7; P60899;
703-753
100MG;ZN;
Structure of active transcription elongation complex Pol II-DSIF (SPT5-KOW5)-ELL2-EAF1 (composite s… Heteromer
A0A287ADR4; A0A4X1TRS6; A0A4X1VEK9; A0A4X1VYD0; A0A7M4DUC2; F1RKE4; I3LCB2; I3LCH3; I3LGP4; I3LSI7; O00472; P60899; Q96JC9;
703-753
100MG;ZN;
The crystal structure of a self-peptide complexed to Abacavir and HLA-B*57:01 Heteromer
P01889; P61769;
980-988
1001KX;
Crystal Structure of Human Rtf1 Plus3 Domain in Complex with Spt5 CTR Phosphopeptide Heteromer
Q92541;
781-788
100SO4;
4th KOW domain of human hSpt5monomer533-647
100
6th KOW domain of human hSpt5monomer974-1087
100
Crystal structure of the KOWx-KOW4 domain of human DSIFmonomer536-646
100GOL;
Crystal structure of the KOW6-KOW7 domain of human DSIFmonomer979-1086
100CL;NA;
Solution structure of the fifth KOW motif of human transcription elongation factor SPT5monomer694-757
100
Solution structure of the third KOW motif of transcription elongation factor SPT5monomer462-523
100
Solution structure of the second KOW motif of human transcription elongation factor SPT5monomer420-471
100

3 SWISS-MODEL models

TemplateOligo-stateQMEANDisCoRangeLigandsTrg-Tpl Seq id (%)
6gmh.1.Wmonomer0.68176-754
100.00
8p4d.1.Rmonomer0.65176-753
100.00
8p4c.1.Rmonomer0.63176-753
100.00

3 SWISS-MODEL models built on isoform sequence

IsoformTemplateOligo-stateQMEANDisCoRangeLigandsTrg-Tpl Seq id (%)
Isoform 26gmh.1.Wmonomer0.68172-750
99.54
Isoform 28p4d.1.Rmonomer0.64172-749
99.54
Isoform 28p4c.1.Rmonomer0.62172-749
99.54